In a newly created award, pRED`s Discovery Oncology unit of Roche (RHHBY) in Penzberg, Germany invites European researchers to submit abstracts which describe their scientific work in the field of tumor-selective membrane targets for antibody-based cancer therapy. The award aims to honor and support more
To use all functions of this page, please activate cookies in your browser.
